NCT00974597终止不适用
A Randomized, Prospective Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery
Aubrey Inc.2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Compare rate of healing of donor sites
研究概览
简要总结
The purpose of this study is to examine AWBAT™-D compared to Mepilex® Ag for the treatment of donor sites in burn surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Burn wounds requiring skin grafting
- •Matched donor sites available
- •1-30% TBSA
排除标准
- •Severe inhalation injury
- •Pregnancy
- •Co-morbidity which may compromise healing
- •Known allergy to pork or pork products
结局指标
主要结局
Compare rate of healing of donor sites
时间窗: 6 month follow-up
次要结局
- Compare complication rates(6 month follow-up)
- Compare patient reported perception of pain(6 month follow-up)
- Compare clinical outcome (scarring)(6 month follow-up)
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
3 期
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to MethotrexateRheumatoid ArthritisNCT04909801Bristol-Myers Squibb338
进行中（未招募）
3 期
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCProstate CancerNCT02489318Aragon Pharmaceuticals, Inc.1,052
已完成
4 期
Mechanism of Action Study for PsoriasisPsoriasisNCT00932113Tufts Medical Center33
终止
2 期
Efficacy and Safety Study of Abatacept to Treat Lupus NephritisSystemic Lupus ErythematosusNCT00430677Bristol-Myers Squibb423
暂停
2 期
ABBA CORD: dCBT w/ Abatacept for aGVHD ProphylaxisLymphomaChronic Myelogenous LeukemiaChronic Myelomonocytic LeukemiaHodgkin LymphomaNCT06680661Leland Metheny20